Best Henry Meds Alternatives for GLP-1 Treatment in 2026 — 2026

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Henry Meds' month-to-month injectable semaglutide costs $297/month (captured September 4, 2026); PlexusDx charges $189/month, a difference of $1,296 over twelve months. Henry Meds offers a wider oral medication menu—sublingual semaglutide tablets at $249/month, oral tirzepatide (not injectable), liraglutide at an introductory $179/month for the first month (standard rate $179/month thereafter), and a microdose oral option advertised at an introductory $179/month for the first month—but does not offer injectable tirzepatide. PlexusDx offers injectable tirzepatide at $289/month, oral semaglutide at $289/month, oral tirzepatide, and a microdose GLP-1 protocol at $129/month. If you prioritize the lowest monthly cost for injectable semaglutide, PlexusDx delivers a clear advantage. If you prefer oral formats or need liraglutide, Henry Meds may be the better fit. Both include medication, provider visits, supplies, and shipping in one price with no separate membership fees.

At-a-glance comparison: Henry Meds vs PlexusDx

Henry Meds pricing captured September 4 and July 20, 2026; PlexusDx pricing captured July 20 and July 23, 2026. Verify all figures at checkout.

Normalized 12-month costs: like-for-like plans

Comparing providers across identical commitment lengths reveals the true cost differences over a full year.

Injectable semaglutide, month-to-month

• Henry Meds: 12 × $297 = $3,564/year
• PlexusDx: 12 × $189 = $2,268/year
• Difference: PlexusDx saves $1,296/year (our calculation)

Injectable semaglutide, 6-month commitment

• Henry Meds: $1,482 upfront for six months; annualized = 2 × $1,482 = $2,964/year (our calculation, $247/month)
• PlexusDx: $894 upfront for six months; annualized = 2 × $894 = $1,788/year (our calculation, $149/month)
• Difference: PlexusDx saves $1,176/year (our calculation)

Injectable semaglutide, 12-month commitment

Henry Meds offers a 12-month plan at $2,364 paid upfront ($197/month, captured July 20 and September 4, 2026). PlexusDx does not offer a 12-month commitment plan; the longest available is six months. No like-for-like comparison is possible.

Oral semaglutide, month-to-month

• Henry Meds (sublingual): 12 × $249 = $2,988/year
• PlexusDx: 12 × $289 = $3,468/year
• Difference: Henry Meds saves $480/year (our calculation)

Injectable tirzepatide

Henry Meds does not offer injectable tirzepatide (captured July 20 and September 4, 2026). Henry's oral tirzepatide product is advertised at $297/month ($891 for a 3-month supply, captured September 4, 2026), but the checkout page contains conflicting statements—one section says "3-month supply" while another says "delivered every 60 days for 6 months." We recommend confirming the plan structure and total cost directly with Henry Meds at checkout.

PlexusDx offers injectable tirzepatide at $289/month month-to-month and $249/month on a 6-month plan ($1,494 upfront, captured July 20, 2026). Because Henry Meds does not offer injectable tirzepatide, no direct comparison is possible for that route of administration.

Microdose GLP-1

• Henry Meds (premium tablets/drops): 12 × $179 = $2,148/year
• PlexusDx: 12 × $129 = $1,548/year
• Difference: PlexusDx saves $600/year (our calculation)

Medication formats and availability

Henry Meds offers a broader menu of oral GLP-1 formats than PlexusDx. In addition to compounded semaglutide injection, Henry Meds provides sublingual semaglutide tablets, oral tirzepatide (dissolving tablets, not injection), and a "premium" microdose option delivered as tablets or drops (captured September 4 and September 7, 2026). Henry Meds also offers liraglutide injection at $179/month, which PlexusDx does not carry. This range may appeal to patients who prefer non-injection routes or who want access to liraglutide.

PlexusDx offers injectable semaglutide, injectable tirzepatide, oral semaglutide capsules, oral tirzepatide capsules, and a microdose GLP-1 injection (captured July 20 and July 23, 2026). PlexusDx's key differentiator is injectable tirzepatide, which Henry Meds does not provide. Patients seeking tirzepatide injection must look elsewhere if they choose Henry Meds.

Service model and inclusions

Both providers operate on an all-inclusive telehealth model with no separate membership fees. Henry Meds includes medication, online provider visits, injection supplies (for injectable options), and shipping in the advertised price (captured September 4 and September 7, 2026). The initial evaluation is free; you are charged only if a prescription is issued. Cancellation is available anytime via account portal, email (ask@henrymeds.com), or phone (909-787-2342), though multi-month prepaid plans may require paying the remaining balance unless you are medically unable to continue (captured September 7, 2026).

PlexusDx similarly bundles medication, provider visits, supplies, and shipping with no membership fee (captured July 20 and July 23, 2026). Monthly plans can be canceled anytime without penalty. PlexusDx offers an optional genetic testing add-on ($298, or $99 for program members) that analyzes how your genetics may influence GLP-1 medication response and side effects, plus a free check-in with a Doctor of Pharmacy included in the program (captured July 20, 2026).

Review records and reported service quality

Henry Meds holds a 4.4-star rating on Trustpilot with approximately 13,000 reviews (captured September 4, 2026). The large review volume and consistently high rating suggest generally positive patient experiences. Our research pass did not identify a dominant negative theme in Henry Meds reviews.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). Both providers have established review records that support their service claims.

Choose Henry Meds if…

• You prefer an oral or sublingual route and want the lower $249/month price for sublingual semaglutide tablets (vs. PlexusDx oral semaglutide capsules at $289/month).
• You want access to liraglutide injection at $179/month, which PlexusDx does not offer.
• You are willing to prepay 12 months upfront for injectable semaglutide to secure the $197/month rate ($2,364 total), the lowest long-term rate in this comparison.
• You prefer a slightly higher aggregate Trustpilot rating (4.4 vs. 4.3 stars) and larger review volume.
• You do not need injectable tirzepatide (Henry Meds offers oral tirzepatide only).

Choose PlexusDx if…

• You want the lowest month-to-month price for injectable semaglutide—$189/month saves $108/month ($1,296/year) vs. Henry Meds' $297/month.
• You need injectable tirzepatide, which Henry Meds does not offer; PlexusDx provides it at $289/month month-to-month or $249/month on a 6-month plan.
• You prefer a 6-month commitment over a 12-month lockup and want the lowest rate at that tier—PlexusDx injectable semaglutide is $149/month ($894 upfront) vs. Henry Meds' $247/month ($1,482 upfront), a $588 difference over six months (our calculation).
• You want the lowest-cost microdose GLP-1 option—$129/month vs. Henry Meds' $179/month, a $600/year difference (our calculation).
• You value the optional genetic testing add-on and free Doctor of Pharmacy check-in that PlexusDx includes.
• You want flexibility to cancel a monthly plan anytime without prepayment risk.

Compounding pharmacies and regulatory status

Henry Meds works with licensed 503A compounding pharmacies (captured September 7, 2026). PlexusDx works with licensed 503A compounding pharmacies (captured July 20, 2026).

Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Neither compounded semaglutide nor compounded tirzepatide is FDA-approved, and neither is the same as the branded drugs Ozempic, Wegovy, Mounjaro, or Zepbound.

Evidence conflicts and verification advice

Henry Meds' oral tirzepatide checkout page (captured September 4, 2026) contains conflicting statements about plan structure. One section describes a "3-month supply" at $891 upfront ($297/month), while another states medication is "delivered every 60 days for 6 months." The same page also lists a "$1,047 standard total" alongside the $891 figure, and the relationship between these prices is unclear. We recommend confirming the plan length, delivery schedule, and total cost directly with Henry Meds at checkout before committing.

Methodology and freshness

Pricing and plan structures were captured from Henry Meds program pages and product checkout pages on September 4 and September 7, 2026, and from a PlexusDx head-to-head comparison page on July 20, 2026. PlexusDx pricing was captured from PlexusDx product pages on July 20 and July 23, 2026. Trustpilot review ratings and volume were captured September 4, 2026. All twelve-month cost projections are our calculations based on the per-month or per-period rates documented at capture. We did not complete a live checkout with either provider. Readers should verify current pricing, plan terms, and medication availability at checkout, as telehealth programs update offerings and rates periodically.

Frequently Asked Questions

Does Henry Meds offer injectable tirzepatide?

No. Henry Meds offers oral tirzepatide in dissolving-tablet form but does not offer tirzepatide injection (captured September 4, 2026). PlexusDx offers injectable tirzepatide at $289/month month-to-month or $249/month on a 6-month plan.

Which provider has the lowest month-to-month price for injectable semaglutide?

PlexusDx offers injectable semaglutide at $189/month month-to-month (captured July 20, 2026), compared to Henry Meds' $297/month (captured September 4, 2026). Over twelve months, PlexusDx costs $2,268 vs. Henry Meds' $3,564, a difference of $1,296 (our calculation).

Can I cancel a multi-month plan with Henry Meds if I experience side effects?

Henry Meds states you may cancel anytime via portal, email, or phone. However, multi-month prepaid plans may require you to pay the remaining balance unless you are medically unable to continue (captured September 7, 2026). Confirm the cancellation and refund policy for your specific plan at enrollment.

Does either provider charge a membership fee?

No. Both Henry Meds and PlexusDx include medication, provider visits, supplies, and shipping in the advertised price with no separate membership fee (captured September 4 and July 20, 2026).

Which provider is better for oral GLP-1 options?

Henry Meds offers sublingual semaglutide tablets at $249/month, oral tirzepatide, and microdose oral tablets/drops at $179/month (captured September 4, 2026). PlexusDx offers oral semaglutide capsules at $289/month, oral tirzepatide capsules at $349/month month-to-month, and microdose GLP-1 injection at $129/month. Henry Meds has a broader oral menu and lower pricing for sublingual semaglutide; PlexusDx offers lower microdose pricing.

Sources

• Henry Meds program pages and product checkout pages (accessed July 20, September 4, and September 7, 2026)
• PlexusDx product pages and head-to-head comparison page (accessed July 20 and July 23, 2026)
• Trustpilot review profiles for Henry Meds and PlexusDx (accessed September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.